Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 693.45 million compared to CNY 622.65 million a year ago. Revenue was CNY 693.45 million compared to CNY 622.65 million a year ago.

Net income was CNY 77.97 million compared to CNY 73.11 million a year ago. Basic earnings per share from continuing operations was CNY 0.91 compared to CNY 0.8542 a year ago. Diluted earnings per share from continuing operations was CNY 0.8812 compared to CNY 0.8542 a year ago.